NIH, Fox Foundation allies with biopharmas on $24M Parkinson's project; FDA accepts Theravance/Mylan NDA for COPD drug
→ The NIH is teaming up with The Michael J. Fox Foundation and a group of life sciences companies on a $24 million initiative …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
